Healthier Workplaces, A Healthier World

Product Demo: Reducing Legionnaires’ disease risk by testing with Legiolert

Tuesday, April 16, 2019 2:00pm - 2:30pm EDT  
Host: AIHA
By: Dr. Dan Broder, Lead Scientist , IDEXX’s Legiolert™ R&D team

Product Demos are short presentations of practical tips for using a specific product, similar to the demonstrations that take place at conference exhibits. AIHA does not update participants’ educational transcripts for Product Demos.

Product description from IDEXX: The Legiolert® Test is a next-generation culture test to detect Legionella pneumophila, the waterborne bacteria that causes Legionnaires’ disease. Accurate and reliable test results are essential for reducing employees’ Legionnaires’ disease risk through water management plans. This webinar will explain how and why the Legiolert Test’s accuracy and reliability lead to better employee protection.


This Webinar has ended, but you can view its content in the archive below.
Please sign in, or enter the following to view the content archive:


Please register above to view this Webinar.


Dr. Dan Broder
Dr. Dan Broder

Lead Scientist, IDEXX’s Legiolert™ R&D team

Dr. Dan Broder is the lead scientist for IDEXX’s Legiolert R&D team. Legiolert is a new quantitative culture-based method which simplifies the detection of Legionella pneumophila in water samples. He is currently co-authoring international field trial studies on the performance of Legiolert vs. standard method technologies. Previously, Dr. Broder was a senior scientist at a molecular diagnostics company specializing in genetic profile characterization. He earned his PhD in microbiology from the University of Illinois at Urbana-Champaign, where he studied the biochemistry and metabolism associated with proteolytic breakdown in gram negative organisms.